BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 30045751)

  • 1. DNA methylation analysis on purified neurons and glia dissects age and Alzheimer's disease-specific changes in the human cortex.
    Gasparoni G; Bultmann S; Lutsik P; Kraus TFJ; Sordon S; Vlcek J; Dietinger V; Steinmaurer M; Haider M; Mulholland CB; Arzberger T; Roeber S; Riemenschneider M; Kretzschmar HA; Giese A; Leonhardt H; Walter J
    Epigenetics Chromatin; 2018 Jul; 11(1):41. PubMed ID: 30045751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glia-specific APOE epigenetic changes in the Alzheimer's disease brain.
    Tulloch J; Leong L; Thomson Z; Chen S; Lee EG; Keene CD; Millard SP; Yu CE
    Brain Res; 2018 Nov; 1698():179-186. PubMed ID: 30081037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenome-wide association study of Alzheimer's disease replicates 22 differentially methylated positions and 30 differentially methylated regions.
    Li QS; Sun Y; Wang T
    Clin Epigenetics; 2020 Oct; 12(1):149. PubMed ID: 33069246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel profiling of DNA methylation and hydroxymethylation highlights neuropathology-associated epigenetic variation in Alzheimer's disease.
    Smith AR; Smith RG; Pishva E; Hannon E; Roubroeks JAY; Burrage J; Troakes C; Al-Sarraj S; Sloan C; Mill J; van den Hove DL; Lunnon K
    Clin Epigenetics; 2019 Mar; 11(1):52. PubMed ID: 30898171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine-mapping and replication of EWAS loci harboring putative epigenetic alterations associated with AD neuropathology in a large collection of human brain tissue samples.
    Palma-Gudiel H; Yu L; Huo Z; Yang J; Wang Y; Gu T; Gao C; De Jager PL; Jin P; Bennett DA; Zhao J
    Alzheimers Dement; 2023 Apr; 19(4):1216-1226. PubMed ID: 35959851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated DNA methylation across a 48-kb region spanning the HOXA gene cluster is associated with Alzheimer's disease neuropathology.
    Smith RG; Hannon E; De Jager PL; Chibnik L; Lott SJ; Condliffe D; Smith AR; Haroutunian V; Troakes C; Al-Sarraj S; Bennett DA; Powell J; Lovestone S; Schalkwyk L; Mill J; Lunnon K
    Alzheimers Dement; 2018 Dec; 14(12):1580-1588. PubMed ID: 29550519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal data in peripheral blood confirm that PM20D1 is a quantitative trait locus (QTL) for Alzheimer's disease and implicate its dynamic role in disease progression.
    Wang Q; Chen Y; Readhead B; Chen K; Su Y; Reiman EM; Dudley JT
    Clin Epigenetics; 2020 Dec; 12(1):189. PubMed ID: 33298155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-tissue epigenetic analysis identifies distinct associations underlying insulin resistance and Alzheimer's disease at CPT1A locus.
    Sarnowski C; Huan T; Ma Y; Joehanes R; Beiser A; DeCarli CS; Heard-Costa NL; Levy D; Lin H; Liu CT; Liu C; Meigs JB; Satizabal CL; Florez JC; Hivert MF; Dupuis J; De Jager PL; Bennett DA; Seshadri S; Morrison AC
    Clin Epigenetics; 2023 Oct; 15(1):173. PubMed ID: 37891690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Entorhinal cortex epigenome-wide association study highlights four novel loci showing differential methylation in Alzheimer's disease.
    Sommerer Y; Dobricic V; Schilling M; Ohlei O; Sabet SS; Wesse T; Fuß J; Franzenburg S; Franke A; Parkkinen L; Lill CM; Bertram L
    Alzheimers Res Ther; 2023 May; 15(1):92. PubMed ID: 37149695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered CpG methylation in sporadic Alzheimer's disease is associated with APP and MAPT dysregulation.
    Iwata A; Nagata K; Hatsuta H; Takuma H; Bundo M; Iwamoto K; Tamaoka A; Murayama S; Saido T; Tsuji S
    Hum Mol Genet; 2014 Feb; 23(3):648-56. PubMed ID: 24101602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide DNA methylation profiling in the superior temporal gyrus reveals epigenetic signatures associated with Alzheimer's disease.
    Watson CT; Roussos P; Garg P; Ho DJ; Azam N; Katsel PL; Haroutunian V; Sharp AJ
    Genome Med; 2016 Jan; 8(1):5. PubMed ID: 26803900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylomic profiling in trisomy 21 identifies cognition- and Alzheimer's disease-related dysregulation.
    Haertle L; Müller T; Lardenoije R; Maierhofer A; Dittrich M; Riemens RJM; Stora S; Roche M; Leber M; Riedel-Heller S; Wagner M; Scherer M; Ravel A; Mircher C; Cieuta-Walti C; Durand S; van de Hove DLA; Hoffmann P; Ramirez A; Haaf T; El Hajj N; Mégarbané A
    Clin Epigenetics; 2019 Dec; 11(1):195. PubMed ID: 31843015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related epigenetic changes in hippocampal subregions of four animal models of Alzheimer's disease.
    Lardenoije R; van den Hove DLA; Havermans M; van Casteren A; Le KX; Palmour R; Lemere CA; Rutten BPF
    Mol Cell Neurosci; 2018 Jan; 86():1-15. PubMed ID: 29113959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A machine learning approach to brain epigenetic analysis reveals kinases associated with Alzheimer's disease.
    Huang Y; Sun X; Jiang H; Yu S; Robins C; Armstrong MJ; Li R; Mei Z; Shi X; Gerasimov ES; De Jager PL; Bennett DA; Wingo AP; Jin P; Wingo TS; Qin ZS
    Nat Commun; 2021 Jul; 12(1):4472. PubMed ID: 34294691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated DNA methylation and gene expression profiling across multiple brain regions implicate novel genes in Alzheimer's disease.
    Semick SA; Bharadwaj RA; Collado-Torres L; Tao R; Shin JH; Deep-Soboslay A; Weiss JR; Weinberger DR; Hyde TM; Kleinman JE; Jaffe AE; Mattay VS
    Acta Neuropathol; 2019 Apr; 137(4):557-569. PubMed ID: 30712078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated DNA Methylation/RNA Profiling in Middle Temporal Gyrus of Alzheimer's Disease.
    Piras IS; Brokaw D; Kong Y; Weisenberger DJ; Krate J; Delvaux E; Mahurkar S; Blattler A; Siegmund KD; Sue L; Serrano GE; Beach TG; Laird PW; Huentelman MJ; Coleman PD
    Cell Mol Neurobiol; 2023 Jul; 43(5):2289-2307. PubMed ID: 36596913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenome-wide association studies in Alzheimer's disease; achievements and challenges.
    van den Hove DLA; Riemens RJM; Koulousakis P; Pishva E
    Brain Pathol; 2020 Sep; 30(5):978-983. PubMed ID: 32654262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrative genomics approach identifies conserved transcriptomic networks in Alzheimer's disease.
    Morabito S; Miyoshi E; Michael N; Swarup V
    Hum Mol Genet; 2020 Oct; 29(17):2899-2919. PubMed ID: 32803238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-tissue analysis of blood and brain epigenome-wide association studies in Alzheimer's disease.
    C Silva T; Young JI; Zhang L; Gomez L; Schmidt MA; Varma A; Chen XS; Martin ER; Wang L
    Nat Commun; 2022 Aug; 13(1):4852. PubMed ID: 35982059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigenetic modifications in Alzheimer's disease: cause or effect?
    Piaceri I; Raspanti B; Tedde A; Bagnoli S; Sorbi S; Nacmias B
    J Alzheimers Dis; 2015; 43(4):1169-73. PubMed ID: 25159670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.